Urata S, Yoshikawa R, and *Yasuda J: Calcium Influx Regulates the Replication of Several Negative-Strand RNA Viruses Including Severe Fever with Thrombocytopenia Syndrome Virus. J Virol 97(3): e0001523, 2023.
Yoshikawa R, Kawakami M, Yasuda J: The NSs protein of severe fever with thrombocytopenia syndrome virus differentially inhibits the type 1 interferon response among animal species. J Biol Chem. 299(6): 104819, 2023.
Kawasaki Y, Abe H, Yasuda J: Comparison of genome replication fidelity between SARSCoV-2 and influenza A virus in cell culture.Sci Rep. 11;13(1): 13105, 2023.
Abe H, Ushijima Y, Bikangui R, Ondo GN, Pemba CM, Zadeh VR, Mpingabo PI, Ueda H, Agnandji ST, Lell B, Yasuda J: Genetic Diversity of Hepatitis B and C Viruses Revealed by Continuous Surveillance from 2015 to 2021 in Gabon, Central Africa. Microorganisms. 11(8): 2046, 2023.
Bikangui R, Boussougou-Sambe ST, Saidou M, Ngossanga B, Doumba Ndalembouly AG, Djida Y, Ayong More, Beh Mba R, Abe H, Ushijima Y, Borrmann S, Lell B, Yasuda J: Adegnika AA. Distribution of Aedes mosquito species along the rural-urban gradient in Lambaréné and its surrounding. Parasit Vectors. 16(1): 360, 2023.
Amano M, Sapkanarak K, Thbthimthong W, Meesawat S, Kemthong T, Suttisan N, Abe H, Malaivijitnond S, Yasuda J: Development of Quantitative Real-Time PCR and Loop-Mediated Isothermal Amplification Assays for the Surveillance and Diagnosis of Herpes B Virus Infection.Viruses. 15(10): 2086, 2023.
2022
Ngwe Tun MM, Sakura T, Sakurai Y, Kurosaki Y, Inaoka DK, Shioda N, Yasuda J, Kita K, Morita K: Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2. Trop Med Health, 50(1):6, 2022.
Abe H, Ushijima Y, Amano M, Sakurai Y, Yoshikawa R, Kinoshita T, Kurosaki Y, Yanagihara K, Izumikawa K, Morita K, Kohno S, *Yasuda J: Unique Evolution of SARS-CoV-2 in the Second Large Cruise Ship Cluster in Japan. Microorganisms, 10(1), 99, 2022.
Moni BM, Sakurai Y, *Yasuda J: Ebola Virus GP Activates Endothelial Cells via Host Cytoskeletal Signaling Factors. Viruses. 14(1), 142, 2022.
Masuda A, Lee JM, Miyata T, Mon H, Sato K, Oyama K, Sakurai Y, Yasuda J, Takahashi D, Ueda T, Kato Y, Nishida M, Karasaki N, Kakino K, Ebihara T, Nagasato T, Hino M, Nakashima A, Suzuki K, Tonooka Y, Tanaka M, Moriyama T, Nakatake H, Fujita R, Kusakabe T:Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants. Front Immunol. 12:803647, 2022.
Urata S, Omotuyi OI, Izumisawa A, Ishikawa T, Mizuta S, Sakurai Y, Mizutani T, Ueda H, Tanaka Y, and *Yasuda J: Identification of novel chemical compounds targeting filovirus VP40-mediated particle production. Antiviral Res. 199, 105267, 2022.
Hirano M, Sakurai Y, Urata S, Kurosaki Y, Yasuda J, Yoshii KA screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo emorrhagic fever virus.Antiviral Res. 200, 105276, 2022.
Abe H, Ushijima Y, Bikangui R, Ondo GN, Lell B, Adegnika AA, *Yasuda J: Delays in the arrival of the waves of COVID-19: a comparison between Gabon and the African continent. Lancet Microbe, 3 (7), e476, 2022.
Ngwe Tun MM, Sakura T, Sakurai Y, Kurosaki Y, Inaoka DK, Shioda N, Smith C, Yasuda J, Morita K, Kita K: 5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro. Trop Med Health. 50(1):30, 2022.
Zadeh VR, Afowowe TO, Abe H, Urata S, *Yasuda J: Potential and action mechanism of favipiravir as an antiviral against Junin virus. PLOS Pathogens, 18(7), e1010689, 2022.
Ushijima Y, Abe H, Mbadinga MJVM, Ondo GN, Bikangui R, Agnandji ST, Lell B, *Yasuda J: Re-emergence of dengue, chikungunya, and Zika viruses in 2021 after a 10-year gap in Gabon. International Journal of Infectious Diseases Regions, 5, 68-71, 2022.
Ozeki T, Abe H, Ushijima Y, Nze-Nkogue C, Akomo-Okoue EF, Ella GWE, Koumba LBM, Nso BCBB, Mintsa-Nguema R, Makouloutou-Nzassi P, Makanga BK, Nguelet FLM, Ondo GN, Mbadinga MJVM, Igasaki Y, Okada S., Hirano M, Yoshii K, Lell B, Bonney LC, Hewson R, Kurosaki Y, *Yasuda J: Identification of novel orthonairoviruses from rodents and shrews in Gabon, Central Africa. Journal of General Virology, 103(10), 001796, 2022.
Tegally H, San JE, Cotton M, ..., Abe H, …, Yasuda J, et al: The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance. Science, 378(6615), eabq5358, 2022.
Abe H, Ushijima Y, Bikangui R, Ondo GN, Moure A, Yali-Assy-Oyamli Y, Yoshikawa R, Lell B, Adegnika AA, *Yasuda J: Long-term validation of a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 from March 2020 to October 2021 in Central Africa, Gabon. PLOS Neglected Tropical Diseases, 16(12), e0010964, 2022.
2021
Sakurai Y, Ngwe Tun MM, Kurosaki Y, Sakura T, Inaoka DK, Fujine K, Kita K, Morita K, Yasuda J: 5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro.Biochem Biophys Res Commun 545: 203-207, 2021.
Ushijima Y, Abe H, Ozeki T, Ondo GN, Mbadinga MJVM, Bikangui R, Nze-Nkogue C, Akomo-Okoue EF, Ella GWE, Koumba LBM, Nso BCBB, Mintsa-Nguema R, Makouloutou-Nzassi P, Makanga BK, Nguelet FLM, Zadeh VR, Urata S, Mbouna AVN, Massinga-Loembe M, Agnandji ST, Lell B, Yasuda J: Identification of potential novel hosts and the risk of infection with lymphocytic choriomeningitis virus in humans in Gabon, Central Africa. Int J Infect Dis 105: 452-459, 2021.
Ushijima Y, Abe H, Nguema Ondo G, Bikangui R, Massinga Loemb? M, Zadeh VR, Essimengane JGE, Mbouna AVN, Bache EB, Agnandji ST, Lell B, Yasuda J: Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections.BMC Infect Dis 21(1): 265, 2021.
Imamura K, Sakurai Y, Enami T, Shibukawa R, Nishi Y, Ohta A, Shu T, Kawaguchi J, Okada S, Hoenen T, Yasuda J, Inoue H: iPSC screening for drug repurposing identifies anti-RNA virus agents modulating host cell susceptibility.FEBS Open Bio 11(5): 1452-1464, 2021.
Abe H, Ushijima Y, Bikangui R, Zoa-Assoumou S, Ondo GN, Manouana GP, More A, Skarwan E, Yali-Assy-Oyamli Y, Ndeboko B, Myrabelle Avome Houechenou R, Djoba Siawaya JF, Lell B, Adegnika AA, Yasuda J: Unrecognized introduction of SARS-CoV-2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent. J Med Virol 93(10): 6054-6058, 2021.
Kinoshita T, Watanabe K, Sakurai Y, Nishi K, Yoshikawa R, Yasuda J: Co-infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters. Sci Rep 11(1): 21259, 2021.
Wilkinson E, Giovanetti M, Tegally H, San JE, Lessells R, Cuadros D, Martin DP, Rasmussen DA, Zekri AN, Sangare AK, Ouedraogo AS, Sesay AK, Priscilla A, Kemi AS, Olubusuyi AM, Oluwapelumi AOO, Hammami A, Amuri AA, Sayed A, Ouma AEO, Elargoubi A, Ajayi NA, Victoria AF, Kazeem A, George A, Trotter AJ, Yahaya AA, Keita AK, Diallo A, Kone A, Souissi A, Chtourou A, Gutierrez AV, Page AJ, Vinze A, Iranzadeh A, Lambisia A, Ismail A, Rosemary A, Sylverken A, Femi A, Ibrahimi A, Marycelin B, Oderinde BS, Bolajoko B, Dhaala B, Herring BL, Njanpop-Lafourcade BM, Kleinhans B, McInnis B, Tegomoh B, Brook C, Pratt CB, Scheepers C, Akoua-Koffi CG, Agoti CN, Peyrefitte C, Daubenberger C, Morang'a CM, Nokes DJ, Amoako DG, Bugembe DL, Park D, Baker D, Doolabh D, Ssemwanga D, Tshiabuila D, Bassirou D, Amuzu DSY, Goedhals D, Omuoyo DO, Maruapula D, Foster-Nyarko E, Lusamaki EK, Simulundu E, Ong'era EM, Ngabana EN, Shumba E, El Fahime E, Lokilo E, Mukantwari E, Philomena E, Belarbi E, Simon-Loriere E, Anoh EA, Leendertz F, Ajili F, Enoch FO, Wasfi F, Abdelmoula F, Mosha FS, Takawira FT, Derrar F, Bouzid F, Onikepe F, Adeola F, Muyembe FM, Tanser F, Dratibi FA, Mbunsu GK, Thilliez G, Kay GL, Githinji G, van Zyl G, Awandare GA, Schubert G, Maphalala GP, Ranaivoson HC, Lemriss H, Anise H, Abe H, Karray HH, Nansumba H, Elgahzaly HA, Gumbo H, Smeti I, Ayed IB, Odia I, Ben Boubaker IB, Gaaloul I, Gazy I, Mudau I, Ssewanyana I, Konstantinus I, Lekana-Douk JB, Makangara JC, Tamfum JM, Heraud JM, Shaffer JG, Giandhari J, Li J, Yasuda J, Mends JQ, Kiconco J, Morobe JM, Gyapong JO, Okolie JC, Kayiwa JT, Edwards JA, Gyamfi J, Farah J, Nakaseegu J, Ngoi JM, Namulondo J, Andeko JC, Lutwama JJ, O'Grady J, Siddle K, Adeyemi KT, Tumedi KA, Said KM, Hae-Young K, Duedu KO, Belyamani L, Fki-Berrajah L, Singh L, Martins LO, Tyers L, Ramuth M, Mastouri M, Aouni M, El Hefnawi M, Matsheka MI, Kebabonye M, Diop M, Turki M, Paye M, Nyaga MM, Mareka M, Damaris MM, Mburu MW, Mpina M, Nwando M, Owusu M, Wiley MR, Youtchou MT, Ayekaba MO, Abouelhoda M, Seadawy MG, Khalifa MK, Sekhele M, Ouadghiri M, Diagne MM, Mwenda M, Allam M, Phan MVT, Abid N, Touil N, Rujeni N, Kharrat N, Ismael N, Dia N, Mabunda N, Hsiao NY, Silochi NB, Nsenga N, Gumede N, Mulder N, Ndodo N, Razanajatovo NH, Iguosadolo N, Judith O, Kingsley OC, Sylvanus O, Peter O, Femi O, Idowu O, Testimony O, Chukwuma OE, Ogah OE, Onwuamah CK, Cyril O, Faye O, Tomori O, Ondoa P, Combe P, Semanda P, Oluniyi PE, Arnaldo P, Quashie PK, Dussart P, Bester PA, Mbala PK, Ayivor-Djanie R, Njouom R, Phillips RO, Gorman R, Kingsley RA, Carr RAA, El Kabbaj S, Gargouri S, Masmoudi S, Sankhe S, Lawal SB, Kassim S, Trabelsi S, Metha S, Kammoun S, Lemriss S, Agwa SHA, Calvignac-Spencer S, Schaffner SF, Doumbia S, Mandanda SM, Aryeetey S, Ahmed SS, Elhamoumi S, Andriamandimby S, Tope S, Lekana-Douki S, Prosolek S, Ouangraoua S, Mundeke SA, Rudder S, Panji S, Pillay S, Engelbrecht S, Nabadda S, Behillil S, Budiaki SL, van der Werf S, Mashe T, Aanniz T, Mohale T, Le-Viet T, Schindler T, Anyaneji UJ, Chinedu U, Ramphal U, Jessica U, George U, Fonseca V, Enouf V, Gorova V, Roshdy WH, Ampofo WK, Preiser W, Choga WT, Bediako Y, Naidoo Y, Butera Y, de Laurent ZR, Sall AA, Rebai A, von Gottberg A, Kouriba B, Williamson C, Bridges DJ, Chikwe I, Bhiman JN, Mine M, Cotten M, Moyo S, Gaseitsiwe S, Saasa N, Sabeti PC, Kaleebu P, Tebeje YK, Tessema SK, Happi C, Nkengasong J, de Oliveira T. A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa. Science 374(6566): 423-431, 2021.
Maeda H, Sando E, Toizumi M, Arima Y, Shimada T, Tanaka T, Tashiro M, Fujita A, Yanagihara K, Takayama H, Yasuda I, Kawachi N, Kohayagawa Y, Hasegawa M, Motomura K, Fujita R, Nakata K, Yasuda J, Morita K, Kohno S, Izumikawa K, Suzuki M, Morimoto K: Epidemiology of Coronavirus Disease Outbreak among Crewmembers on Cruise Ship, Nagasaki City, Japan, April 2020. Emerg Infect Dis 27(9): 2251-2260, 2021.
Mutantu PN, Ngwe Tun MM, Nabeshima T, Yu F, Mukadi PK, Tanaka T, Tashiro M, Fujita A, Kanie N, Oshiro R, Takazono T, Imamura Y, Hirayama T, Moi ML, Inoue S, Izumikawa K, Yasuda J, Morita K. Development and Evaluation of Quantitative Immunoglobulin G Enzyme-Linked Immunosorbent Assay for the Diagnosis of Coronavirus Disease 2019 Using Truncated Recombinant Nucleocapsid Protein as Assay Antigen. Int J Environ Res Public Health. 18(18):9630, 2021.
Kaku N, Nishimura F, Shigeishi Y, Tachiki R, Sakai H, Sasaki D, Ota K, Sakamoto K, Kosai K, Hasegawa H, Izumikawa K, Ariyoshi K, Mukae H, Yasuda J, Morita K, Kohno S, Yanagihara K: Performance of anti-SARS-CoV-2 antibody testing in asymptomatic or mild COVID-19 patients: A retrospective study in outbreak on a cruise ship. PLoS One 16(9): e0257452, 2021.
Zoa-Assoumou S, Ndeboko B, Manouana GP, Houechenou RMA, Bikangui R, Mveang-Nzoghe A, Ondo GN, Mbongo-Kama E, Lell B, Abe H, Ushijima Y, Antchouey AM, Yasuda J, Adegnika AA, Siawaya JFD: SARS-CoV-2 emerging variants in Africa: view from Gabon. Lancet Microbe 2(8): e349, 2021.
Ota K, Yanagihara K, Sasaki D, Kaku N, Uno N, Sakamoto K, Kosai K, Miyazaki T, Hasegawa H, Fujita A, Tashiro M, Tanaka T, Izumikawa K, Ariyoshi K, Mukae H, Yasuda J, Morita K, Kohno S: Detection of SARS-CoV-2 using qRT-PCR in saliva obtained from asymptomatic or mild COVID-19 patients, comparative analysis with matched nasopharyngeal samples. PLoS One 16(6): e0252964, 2021.
Urata S, Yasuda J, Iwasaki M: Loperamide Inhibits Replication of Severe Fever with Thrombocytopenia Syndrome Virus. Viruses 13(5): 869, 2021.
2020
Abe H, Ushijima Y, Bikangui R, Loembe MM, Agnandji ST, de Vries SG, Grobusch MP, Lell B, Yasuda J: Ongoing evolution of hepatitis B virus during viremia in patients with febrile in Central Africa. J Med Virol 92(2): 251-256, 2020.
Yoshikawa R*, Abe H*, Igasaki Y, Negishi S, Goto H, Yasuda J: Development and evaluation of a rapid and simple diagnostic assay for COVID-19 based on loop-mediated isothermal amplification. PLoS Negl Trop Dis 14(11): e0008855, 2020 * These authors contributed equally to this work.
Abe H, Ushijima Y, Bikangui R, Ondo GN, Zadeh VR, Pemba CM, Mpingabo PI, Igasaki Y, de Vries SG, Grobusch MP, Loembe MM, Agnandji ST, Lell B, Yasuda J: First evidence for continuous circulation of hepatitis A virus subgenotype IIA in Central Africa J Viral Hepat 27(11): 1234-1242, 2020.
Zadeh VR, Urata S, Sakaguchi M, Yasuda J: Human BST-2/tetherin inhibits Junin virus release from host cells and its inhibition is partially counteracted by viral nucleoprotein. J Gen Virol 101(6): 573-586, 2020.
Mpingabo PI, Urata S, Yasuda J: Analysis of the Cell Type-Dependence on the Arenavirus Z-Mediated Virus-Like Particle Production. Front Microbiol 11: 562814, 2020.
Abe H, Ushijima Y, Loembe MM, Bikangui R, Nguema-Ondo G, Mpingabo PI, Zadeh VR, Pemba CM, Kurosaki Y, Igasaki Y, Vries SG, Grobusch MP, Agnandji ST, Lell B, Yasuda J: Re-emergence of dengue virus serotype 3 infections in Gabon in 2016-2017, and evidence for the risk of repeated dengue virus infections. Int J Infect Dis 91: 129-136, 2020.
Mizutani T, Ohba Y, Mizuta S, Yasuda J, Urata S: An antiviral drug screening platform with a FRET biosensor for measurement of arenavirus Z assembly. Cell Struct Funct 45(2): 155-163, 2020.
Primadharsini PP, Nagashima S, Takahashi M, Kobayashi T, Nishiyama T, Nishizawa T, Yasuda J, Mulyanto, Okamoto H: Multivesicular body sorting and the exosomal pathway are required for the release of rat hepatitis E virus from infected cells. Virus Res 278, 2020.
2019
Urata S, Ishikawa T, Yasuda J：Roles of YIGL sequence of Ebola virus VP40 on genome replication and particle production. J Gen Virol 100(7) : 1099-1111, 2019.
Pemba CM, Kurosaki Y, Yoshikawa R, Oloniniyi OK, Urata S, Sueyoshi M, Zadeh VR, Nwafor I, Iroezindu MO, Ajayi NA, Chukwubike CM, Chika-Igwenyi NM, Ndu AC, Nwidi DU, Maehira Y, Unigwe US, Ojide CK, Onwe EO, Yasuda J：Development of an RT-LAMP assay for the detection of Lassa viruses in southeast and south-central Nigeria. J Virol Methods 269 : 30-37, 2019.
Yoshikawa R, Sakabe S, Urata S, Yasuda J：Species-specific pathogenicity of severe fever with thrombocytopenia syndrome virus is determined by anti-STAT2 activity of NSs. J Virol 93(10) : e02226-18, 2019.
2018
Oloniniyi, O.K., Unigwe, U.S., Okada, S., Kimura, M., Koyano, S., Miyazaki, Y., Iroezindu, M.O., Ajayi, N.A., Chukwubike, C.M., Chika-Igwenyi, N.M., Ndu, A.C., Nwidi, D.U., Abe, H., Urata, S., Kurosaki, Y., and *Yasuda, J.: Genetic characterization of Lassa virus strains isolated from 2012 to 2016 in southeastern Nigeria. PLOS Neglected Tropical Diseases, 12(11): e0006971, 2018.
Arima, A., Harlisa, I.H., Yoshida, T., Tsutsui, M., Tanaka, M., Yokota, K., Tonomura, W., Yasuda, J., Taniguchi, M., Washio, T., Okochi, M., and Kawai, T.: Identifying Single Viruses Using Biorecognition Solid-State Nanopores. Journal of the American Chemical Society, 140: 16834-16841, 2018.
Urata, S., Kenyon, E., Nayak, D., Cubitt, B., Kurosaki, Y., Yasuda, J., de la Torre, J.C., and McGavern, D.B.: BST-2 controls T cell proliferation and exhaustion by shaping the early distribution of a persistent viral infection. PLOS Pathogens, 14(7): e1007172, 2018.
Urata, S., Uno, Y., Kurosaki, Y., and *Yasuda, J.: The cholesterol, fatty acid and triglyceride synthesis pathways regulated by site 1 protease (S1P) are required for efficient replication of severe fever with thrombocytopenia syndrome virus. Biochem Biophys Res Commun, 503(2):631-636, 2018.
Kurosaki Y, Ueda MT, Nakano Y, Yasuda J, Koyanagi Y, Sato K, Nakagawa S. Different effects of two mutations on the infectivity of Ebola virus glycoprotein in nine mammalian species. J Gen Virol. 2018.
2017
Kurosaki Y*, Ueda MT, Nakano Y, Yasuda J, Koyanagi Y, Sato K, Nakagawa S*: Different effects of two mutations on the infectivity of Ebola virus glycoprotein in nine mammalian species. J Gen Virol, 99(2):181-186, 2018.
Kurosaki, Y., Martins, D.B.G., Kimura, M., Catena, A.D.S., Borba, M.A.C.S.M., Mattos, S.D.S., Abe, H., Yoshikawa, R., de Lima Filho, J.L., and *Yasuda, J. : Development and evaluation of a rapid molecular diagnostic test for Zika virus infection by reverse transcription loop-mediated isothermal amplification. Scientific Reports, 7(1):13503, 2017.
Howson, E.L.A., Kurosaki, Y., Yasuda, J., Takahashi, M., Goto, H., Gray, A.R., Mioulet, V., King, D.P., and Fowler, V.L.: Defining the relative performance of isothermal assays that can be used for rapid and sensitive detection of foot-and-mouth disease virus. Journal of Virological Methods, 249, 102-110, 2017.
Oloniniyi, O.K., Kurosaki, Y., Miyamoto, H., Takada, and *Yasuda, J.: Rapid detection of all known ebolavirus species by reversetranscription-loop-mediated isothermal amplification (RT-LAMP). Journal of Virological Methods, 246, 8-14, 2017.
Ueda, M.T., Kurosaki, Y, Izumi, T., Nakano, Y., Oloniniyi, O.K., Yasuda, J., Koyanagi, Y., Sato, K., and Nakagawa, S.: Functional mutations in spike glycoprotein of Zaire ebolavirus associated with an increase in infection efficiency. Genes to Cells, 22(2), 148-159, 2017.
Sakurai, T., Nakagawa, S., Bai, H., Bai, R., Kusama, K., Ideta, A., Aoyagi, Y., Kaneko, K., Iga, K., Yasuda, J., Miyazawa, T., and Imakawa, K.: Novel endogenous retrovirus-derived transcript expressed in the bovine placenta is regulated by WNT signaling. Biochemical Journal, 474, 3499-3512, 2017.
Watanabe, K., Ishikawa, T., Otaki, H., Mizuta, S., Hamada, T., Nakagaki, T., Ishibashi, D., Urata, S., Yasuda, J., Tanaka, Y., and Nishida, N.: Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction. Scientific Reports, 7(1):9500, 2017.
Kusama, K., Bai, R., Nakamura, K., Okada, S., Yasuda, J., and Imakawa, K.: Endometrial factors similarly induced by IFNT2 and IFNTc1 through transcription factor FOXS1. PLOS One, 12(2): e0171858, 2017.
2016
Kurosaki Y., Okada S., Nakamae S., and *Yasuda J.: A loop-mediated isothermal amplification assay for rapid and sensitive detection of bovine papular stomatitis virus. Journal of Virological Methods, 238, 42-47, 2016.
Maehira Y., Jakimo A.L., Saito T., Kurosaki Y., Yasuda J., Tarui M., Malvy D.J.M, and Takeuchi T.: Responding to ever-changing epidemiological dynamics of Ebola virus disease. BMJ Global Health, in press.
Uchida L., Urata S., Ulanday G.E., Takamatsu Y., Yasuda J., Morita K., and Hayasaka D.: Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation. Viruses, 8 (2), E46 (1-12), 2016.
Shimada S., Aoki K., Nabeshima T., Fuxun Y., Kurosaki Y., Shiogama K., Onouchi T., Sakaguchi M., Fuchigami T., Ono H., Nishi K., Posadas-Herrera G., Uchida L., Takamatsu Y., Yasuda J., Tsutsumi Y., Fujita H., Morita K., and Hayasaka D.: Tofla virus: A newly identified Nairovirus of the Crimean-Congo hemorrhagic fever group isolated from ticks in Japan. Scientific Reports, 6:20213 (1-11), 2016.
Kurosaki Y, Magassouba N, Bah HA, Soropogui B, Dor? A, Kourouma F, Cherif MS, Keita S, Yasuda J:Development of a Reverse Transcription Loop-Mediated Isothermal Amplification Test for Ebola Virus Surveillance in Remote Areas in Guinea. J. Infect Dis. 2016.
Kurosaki Y, Magassouba N, Oloniniyi OK, Cherif MS, Sakabe S, Takada A, Hirayama K, Yasuda J.:Development and Evaluation of Reverse Transcription-Loop-Mediated Isothermal Amplification (RT-LAMP) Assay Coupled with a Portable Device for Rapid Diagnosis of Ebola Virus Disease in Guinea. PLoS Negl Trop Dis. 2016.
Urata S., Weyer J., Storm N., Miyazaki Y., van Vuren P.J., Paweska J.T., and Yasuda J.: Analysis of assembly and budding of Lujo virus. Journal of Virology 90(6):3257-61, 2016.
2015
Yoshikawa R, Miyaho R, Hashimoto A, Abe M, Yasuda J, Miyazawa T: Suppression of production of baboon endogenous virus by dominant negative mutants of cellular factors involved in multivesicular body sorting pathway. Virus Research 196: 128-134, 2015.
Urata S, Yasuda J: Cis- and cell type-dependent trans-requirements for Lassa virus-like particle production. Journal of General Virology 96(7): 1626-1635, 2015.
Narahara C, Yasuda J: Roles of the three L-domains in β-retrovirus budding. Microbiology and Immunology 59: 545-554, 2015.
